Author:
Pandey Ambu,Kalita Kamal Narayan
Abstract
Treatment-resistant schizophrenia is a lack of adequate response to antipsychotic medications resulting in incomplete functional and social recovery from the illness. Different definitions have been proposed for clinical practice and research work. Antipsychotics that are used in the management of schizophrenia mainly act on multiple dopaminergic pathways which are implicated in the development of symptoms of schizophrenia. Newer antipsychotics also are implicated to affect the serotonergic pathways. Clozapine is the only evidence-based treatment available for the management of treatment-resistant cases. Neurobiologically, there is a considerable overlap between treatment-resistant and treatment-responsive cases. The factors that are implicated in the evolution of treatment resistance are still not conclusive. These make the management of such patients a challenge. However, certain peculiarities of treatment-resistant schizophrenia have been identified which can guide us in the early identification and precise treatment of the treatment-resistant cases.
Subject
Psychiatry and Mental health
Reference82 articles.
1. A systematic review of the prevalence of schizophrenia;Saha;PLoS Med.,2005
2. Treatment-resistant schizophrenia-the role of clozapine;Meltzer;Curr Med Res Opin.,1997
3. Esquizofrenia resistente al tratamiento farmacológico;Cervera Enguix;Actas Esp Psiquiatr.,2006
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献